Skip to main content

Table 4 Study III echocardiography

From: Systemic and cardiac susceptibility of immune compromised mice to doxorubicin

   5 weeks
CONTROL DOXORUBICIN
Parameter Unit MEAN SE MEAN SE
LVAW;d mm 0.90 0.11 0.79 0.06
LVAWS;s mm 1.18 0.05 1.04 0.07
LVID;d mm 2.98 0.17 3.50* 0.16
LVID;s mm 1.69 0.14 2.50* 0.22
LVPW;d mm 1.03 0.14 0.81* 0.09
LVPW;s mm 1.40 0.12 1.10* 0.07
Cardiac Output ml/min 15.2 1.0 16.3 0.8
Ejection Fraction % 79.8 3.8 60.0* 6.2
Fractional Shortening % 47.5 3.7 31.8* 4.1
Heart Rate BPM 556.6 29.4 484.3 11.7
Stroke Volume ul 27.4 2.0 33.6* 1.3
Volume;d ul 34.6 3.8 57.0* 4.7
Volume;s ul 7.3 2.1 23.4* 5.7
  N = 2 m, 2f N = 2 m, 2f
  1. LV left ventricle, AW anterior wall, ID internal diameter, PW posterior wall, d diastolic, s systolic, BPM beats per minute. *p < 0.05 paired t-test